Abstract
We report the synthesis of glyco(poly(2-oxazoline)s) functionalized with Pt(II) units for targeted tumor applications. To this end, poly(2-ethyl-2-oxazoline-block-2-(3-butenyl)-2-oxazoline) is modified with thiol-modified acetyl protected glucose and galactose, respectively, and terpyridine (tpy) units using thiol-ene photoaddition. Deprotection of the sugars with sodium methoxide and treatment with Pt(COD)Cl2 applying a mild synthesis route yields polymers with monosaccharide targeting moieties and cytotoxic Pt(II) units. The polymers and intermediates are characterized by 1H nuclear magnetic resonance spectroscopy and size exclusion chromatography. Subsequently, the hemolytic activity, induction of erythrocyte aggregation as well as the cytotoxicity against mouse fibroblast L929 cells, human embryonic kidney cells HEK 293, and human hepatocytes HepG2 are studied. The comparison to cisplatin, the standard for cancer therapy, demonstrates the potential of the presented system. © 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2014, 52, 2703–2714
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Polymer Science Part A: Polymer Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
